2013 Online Spring Shows Exhibitor Preview - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

2013 Online Spring Shows Exhibitor Preview


3M Drug Delivery Systems
View profile

ABB Analytical Measurements
View profile

AdvantaPure
View profile

Ash Stevens
View profile

Baxter BioPharma Solutions
View profile

Cangene bioPharma
View profile

I Holland Limited
View profile

Metrics
View profile

MPI Research
View profile

Patheon
View profile

Pfizer CentreSource
View profile

Pharmatron
View profile

Qualicaps
View profile

Ropack
View profile

Sartorius Stedim North America
View profile

Schenck AccuRate
View profile

Shimadzu
View profile

Thomas Engineering
View profile

VAI
View profile

Vindon Scientific (USA)
View profile

Waters
View profile

Watson-Marlow Pumps Group
View profile

WireCrafters
View profile

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
29%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here